Study Year | # subjects | Age (mean +/- SD) | % male | History of HF (%) | History of asthma or COPD (%) | Patients admitted (%) | BNP assay used | Final diag-nosis HF (%) | Cutoff (pg/ml) | Sensi-tivity (%) | Speci-ficity (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
Jourdain 2002 | 125 | 72†| * | * | * | 100 | Triage | 72 | 300 | 94 | 86 |
Logeart 2002 | 163 | 67 ± 15 | 67 | 49 | * | 90 | Triage | 71 | 100 | 96 | 31 |
Maisel 2002 | 1,586 | 64 ± 17 | 56 | 33 | 41 | 72 | Triage | 47 | 100 | 90 | 76 |
Morrison 2002 | 321 | * | 95 | 42 | 40 | 43 | Triage | 42 | 105 | 86 | 94 |
Villacorta 2002 | 70 | 72 ± 16 | 47 | 37 | 44 | * | Triage | 51 | 200 | 100 | 97 |
Lainchbury 2003 | 205 | 70 ± 14 | 49 | 25 | 42 | * | Triage | 34 | 100 | 77 | 84 |
Knudsen 2004 | 155 | 76†| 45 | * | 47 | * | Triage | 48 | 100 | 90 | 55 |
Ray 2004 | 308 | 80 ± 8 | 50 | 20 | 25 | 100 | Triage | 46 | 100 | 90 | 59 |
Mueller 2005 | 251 | 73†| 93 | 65 | * | * | AxSYM BNP | 55 | 100 | 96 | 61 |
Alibay 2005 | 160 | 80 ± 14 | 48 | 38 | 34 | 58 | Triage | 38 | 150 | 94 | 61 |